AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Net Income (Common)
AstraZeneca PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Net Income (Common)
$6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Income (Common)
£4.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Net Income (Common)
-$54.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Net Income (Common)
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Income (Common)
$190m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Income (Common)
-£27.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's Net Income (Common)?
Net Income (Common)
6B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Net Income (Common) amounts to 6B USD.
What is AstraZeneca PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
9%
Over the last year, the Net Income (Common) growth was 81%. The average annual Net Income (Common) growth rates for AstraZeneca PLC have been 23% over the past three years , 23% over the past five years , and 9% over the past ten years .